Close Menu
    Trending
    • Sumit Woods Expands Mumbai Footprint with Major Bhandup West Project
    • Signoria’s FY25 Revenue Grew by Substantial 39 Percent
    • Top CBSE 2025 Results Put GD Goenka Public School Lucknow in the Spotlight Again
    • Sapphire Media Acquires Radio BIG 92.7 FM, Marks a Crucial Milestone for Indian Radio Industry
    • ‘Sugamya Delhi Abhiyan’ Launched to Make Delhi Accessible and Inclusive for Persons with Disabilities
    • Culturist Sundeep Bhutoria to attend historic Cannes screening of restored Satyajit Ray classic
    • Narayana’s Commitment to Academic Excellence Reflected in CBSE 2025 Results
    • Dhruv Consultancy Services Achieves Strong 360% Cons. Net Profit Growth in Q4 FY25
    Republic News TodayRepublic News Today
    • Business
    • Entertainment
    • Education
    • Health
    • Lifestyle
    • National
    • World
    • Press Release
    Republic News TodayRepublic News Today
    Home»Business»Indian Pharmaceutical Company conducts Clinical Analysis for the Supplement to battle against Post COVID-19 difficulties
    Business

    Indian Pharmaceutical Company conducts Clinical Analysis for the Supplement to battle against Post COVID-19 difficulties

    By June 21, 2021No Comments4 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    ImmunoSEB + ProbioSEB CSC3 for post-resolution of mild to moderate COVID-19 patients

     

    Mumbai, Maharashtra [India], June 21: According to recent stats, 2.77 crores of COVID-19 sufferers were recovered from 2.88 crores cases in India. All corporate offices and businesses want to operate outdoors but worry much about the Post Covid difficulties and resolutions. While companies were involved in launching products and promoting claims that it fights the Coronavirus, researchers ran clinical tests to confirm how consuming immunity supplements resolve mild to moderate COVID-19 patients.

    Dr. Neha Shah, Dr. Rohit Parate, and Dr. Abhay Vispute published their findings on a new COVID-19 clinical trial in the Medical Journal of Advances in Clinical Toxicology. A randomized, open-label, 2 Arm, prospective study was investigated for the safety and efficacy of the health supplements. Fortunately, ImmunoSEB + ProbioSEB CSC3 as supplemental therapy was confirmed to be beneficial in mild to moderate COVID-19 patients and showed overall clinical improvement in WHO 7-point ordinal scale.

    They investigated to evaluate the effect on the primary endpoint of the experimental regimen through pairwise comparisons of the testing regimen ImmunoSEB + ProbioSEB CSC3 with a standard-of-care control arm and under a sequential design. The clinical trials were carried out on 60 patients in two centers, SRV Hospital, Mumbai and Chirayu Medical College, and Hospital, Bhopal.

    As the World Health Organization rightly defines probiotics as “live microorganisms that administer adequate amounts confer a health benefit on the host.” ImmunoSEB + ProbioSEB CSC3 are different as they increase immunity and improves digestion, aiding in reducing fatigue. In addition, it’s a nutraceuticals product, the only product with clinical trials as a supplement to fight against Covid-19.

    Recent clinical studies indicate that this Supplement supports the recovery of covid patients. The length of time to experience the benefits of the Supplement varies by individual. Some people notice a difference within days. For others, it’s a week or ten days. For long-term benefits, it’s essential to take the immunity bundle consistently over several months. Regular, consistent use of the Supplement will provide the best results. However, missed doses of the Supplement do not cause any harm. Consume the following amount as per your daily regime.

    According to Management of Post COVID-19 Fatigue using Systemic Enzymes and Probiotics- Case Series covered by the Medical Journal of Clinical Trials and Case Studies; “The present cases support the use of a 14 days supplementation of a combination of ImmunoSEB + ProbioSEB CSC3 to improve COVID-19 induced fatigue in patients post-resolution of mild to moderate COVID-19 disease. However, there is a need for large-scale, placebo-controlled prospective studies to evaluate this effect further.”

    The team of doctors and researchers includes Dr. Neha Shah, Dr. Rohit Parate, Dr. Abhay Vispute.

    Dr. Rohit Parate, MD Medicine, Churayu Medical College, and Hospital, observes patients with a Generalised Weakness, Dry Cough, Body Ache, Loss of Appetite, and Constipation for post-covid symptoms. Whereas Dr. Kuldeep Kataria, MD Medicine, Swasthya Hospital, follows over 75% of the patients with Sleep disturbance, Severe Body Ache, Abdominal Cramps, and Heaviness in the chest.

    Dr. Sanket Ramesh Mundada, MBBS, DPM, Namrata Neureoschyetric Hospital, Shrirampur conveys, “Post Covid patient with anxiety symptoms, disturbed sleep, depression. Withholding due to the death of the loved ones in Covid, psychosis has increased in OPDs. We have seen cases of fear of getting infected or fear of spreading the infection to family members increasing, causing many palpitations, trembling, sweating in patients. Counseling and appropriate medication help along with immunity booster help maintain the mental and physical health of the patient.”

    “Throughout this pandemic situation, we tried hard to fix this unsolvable puzzle of saving lives post-covid with natural solutions that can help people who are grieving. Enzymes and probiotics are robust mechanisms for stamina and vitality, and the medicine and investigation confirm it.” conveys Dr. Neha Shah, Ph.D. Program Coordinator, Navigate a&Swog, VA Long Beach Healthcare, California.

    Mr. MukundKabra, Director, Advanced Enzymes, states, “the reason is evident for post-COVID-19 and should heal as any prevalent disease. Advanced Enzymes remedied Americans for over 30 years. Aiding to enhance immunity amongst Indians was our prime focus in this pandemic. Hence, the research-backed Immunity Bundle was made available online. Doctors should address post-COVID immunity immediately because it is affecting a lot of people’s quality of life.”

    Dr. Abhijit K Rathi, the Principal Scientist from AET, “ImmunoSEB and Biome Ultra were tested in a few hospitals, clinics, random patients and discovered their feedback. People’s difficulties before the testing were traumatizing. However, after consuming ImmunoSEB and Biome Ultra for some days, the same target group conveyed their curing stories and enhanced immunity evidence.”

    Business
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleSung by the legendary Shri Udit Narayan Ji, Dr. Amit Kamle dedicates his new gospel song ‘Sahayata’ to doctors and frontline workers
    Next Article iTeltronics innovative product iScribe gets recognition at IMC Digital Technology Awards 2020

    Related Posts

    Sapphire Media Acquires Radio BIG 92.7 FM, Marks a Crucial Milestone for Indian Radio Industry

    May 17, 2025

    Let’s Shawarma: Young Entrepreneur Omkar Jadhav’s Journey to Building the Biggest Shawarma Brand in India

    May 17, 2025

    EassyLife Honoured as ‘Best Brand of the Year in E-commerce – Services’ by CNBC TV18

    May 17, 2025
    Recent Posts
    • Sumit Woods Expands Mumbai Footprint with Major Bhandup West Project
    • Signoria’s FY25 Revenue Grew by Substantial 39 Percent
    • Top CBSE 2025 Results Put GD Goenka Public School Lucknow in the Spotlight Again
    • Sapphire Media Acquires Radio BIG 92.7 FM, Marks a Crucial Milestone for Indian Radio Industry
    • ‘Sugamya Delhi Abhiyan’ Launched to Make Delhi Accessible and Inclusive for Persons with Disabilities
    • Culturist Sundeep Bhutoria to attend historic Cannes screening of restored Satyajit Ray classic
    • Narayana’s Commitment to Academic Excellence Reflected in CBSE 2025 Results
    • Dhruv Consultancy Services Achieves Strong 360% Cons. Net Profit Growth in Q4 FY25
    • Intense Technologies Powers Ahead with 32 Percent Growth in Revenue YoY
    • Let’s Shawarma: Young Entrepreneur Omkar Jadhav’s Journey to Building the Biggest Shawarma Brand in India

    Type above and press Enter to search. Press Esc to cancel.